0001388658-20-000280.txt : 20201203
0001388658-20-000280.hdr.sgml : 20201203
20201203180337
ACCESSION NUMBER: 0001388658-20-000280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201201
FILED AS OF DATE: 20201203
DATE AS OF CHANGE: 20201203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vort David A
CENTRAL INDEX KEY: 0001670676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37918
FILM NUMBER: 201367962
MAIL ADDRESS:
STREET 1: C/O IRHYTHM TECHNOLOGIES, INC.
STREET 2: 650 TOWNSEND STREET, SUITE 380
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iRhythm Technologies, Inc.
CENTRAL INDEX KEY: 0001388658
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 208149544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 650 TOWNSEND STREET
STREET 2: SUITE 500
CITY: San Francisco
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-632-5700
MAIL ADDRESS:
STREET 1: 650 TOWNSEND STREET
STREET 2: SUITE 500
CITY: San Francisco
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: IRhythm Technologies, Inc.
DATE OF NAME CHANGE: 20110429
FORMER COMPANY:
FORMER CONFORMED NAME: IRhythm Technologies Inc
DATE OF NAME CHANGE: 20070201
4
1
wf-form4_160703660430501.xml
FORM 4
X0306
4
2020-12-01
0
0001388658
iRhythm Technologies, Inc.
IRTC
0001670676
Vort David A
C/O IRHYTHM TECHNOLOGIES, INC.
699 8TH ST #600
SAN FRANCISCO
CA
94103
0
1
0
0
EVP, Sales
Common Stock
2020-12-01
4
M
0
5000
17
A
20602
D
Common Stock
2020-12-01
4
S
0
596
239.7056
D
20006
D
Common Stock
2020-12-01
4
S
0
1275
241.0109
D
18731
D
Common Stock
2020-12-01
4
S
0
1724
242.1337
D
17007
D
Common Stock
2020-12-01
4
S
0
350
242.89
D
16657
D
Common Stock
2020-12-01
4
S
0
1055
243.9711
D
15602
D
Employee Stock Option (right to buy)
17.0
2020-12-01
4
M
0
5000
0
D
2020-09-21
2026-10-20
Common Stock
5000.0
7777
D
The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
Includes 23 shares acquired pursuant to the issuer's 2016 Employee Stock Purchase Plan on November 30, 2020.
This transaction was executed in multiple trades at prices ranging from $239.295 to $240.12 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $240.465 to $241.43 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $241.62 to $242.59 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $242.65 to $242.93 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $243.715 to $244.51 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This option is fully vested and exercisable in full.
/s/ Christina Delfin, attorney in fact
2020-12-03